Cancer News and Research

Latest Cancer News and Research

Long-term exposure to roadways linked with increased risk of death in patients with heart attack

Living close to a major highway poses a significant risk to heart attack survivors, reinforcing the need to isolate housing developments from heavy traffic areas, a Beth Israel Deaconess Medical Center study concludes.

8 May 2012

Research reveals possible strategy to reverse fibrosis in liver and other organs

An international team of scientists, led by researchers at the University of California, San Diego School of Medicine, report that significant numbers of myofibroblasts - cells that produce the fibrous scarring in chronic liver injury - revert to an inactive phenotype as the liver heals. The discovery in mouse models could ultimately help lead to new human therapies for reversing fibrosis in the liver, and in other organs like the lungs and kidneys.

8 May 2012

iCAD first quarter total revenue decreases 14% to $6.3 million

iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today reported financial results for the first quarter ended March 31, 2012.

8 May 2012

Viewpoints: Diabetes, future health ills & the GOP; Debate on FDA OTC plan; Sen. Brown's daughter's health insurance

A study of diabetes in overweight and obese youngsters bears an ominous warning about future health care trends in this country. It found that Type 2 diabetes, a new scourge among young people, progresses faster and is harder to treat in youngsters than in adults. ... Congressional Republicans, meanwhile, are bent on dismantling health care reforms that could greatly assist in curbing the obesity epidemic.

8 May 2012

Breast cancer in men rarer but more deadly than in women

“Men with breast cancer don't do as well as women with breast cancer, and there are opportunities to improve that,” said study author Dr. Jon Greif, a breast surgeon in San Francisco. “They were less likely to get the standard treatments that women get.” Survival rates for men with breast cancer, overall, are lower than those for women, at least when it is diagnosed in the early stages, Greif found. The cancers differ in other respects too.

8 May 2012

Cheaper anti-blindness drug could save NHS £85 million annually

Avastin (bevacizumab), which is used to treat wet age-related macular degeneration – the most common cause of blindness among the elderly costs only £60 per injection. But despite trials showing it is no less effective, another drug, Lucentis, is the current official choice, even though it costs £700 per shot. Avastin is intended to treat bowel cancer, but research by the National Institute for Health Research has shown that it also works just as effectively and safely as Lucentis in treating Wet AMD.

8 May 2012

Many unaware that persistent cough could be a warning for lung cancer

Most people are aware that that a lump in the breast is a warning sign of breast cancer and bleeding could indicate bowel, kidney or bladder cancer. However, only one in ten people knows that a persistent cough could point to lung cancer.

8 May 2012

Can curry really be beneficial for cancer?

Curcumin is found in the spice turmeric has been linked to a range of health benefits. Studies have already shown that it can beat cancer cells grown in a laboratory and benefits have been suggested in stroke and dementia patients as well. Cucurmin, which acts as an antioxidant and has anti-inflammatory properties, has traditionally been used as an alternative remedy for liver disease, digestive disorders, acne and a range of allergies. Some studies have shown it may slow the spread of cancer, boost the effectiveness of chemotherapy and protect healthy cells from the effects of radiotherapy.

8 May 2012

Pancreatic cancer could be better managed at specialized surgical centres

Pancreatic cancer is one of Australia's most lethal cancers and according to a surgeon it could be better treated by conducting complex surgical procedures in specialised centres. Pancreatic cancer is the fourth biggest cancer killer in Australia.

8 May 2012

Halozyme first quarter net loss increases to $15.1 million

Halozyme Therapeutics, Inc. today reported financial results for the quarter ended March 31, 2012.

8 May 2012

Salix first quarter total product revenue increases 62% to $171.1M

Salix Pharmaceuticals, Ltd. today announced financial and operating results for the first quarter ended March 31, 2012 and other business updates.

8 May 2012

Comfort Solutions commits to raise $1M for St. Jude Children's Research Hospital

Comfort Solutions has committed to raising $1 million by March 31, 2013, for St. Jude Children's Research Hospital, becoming the first major U.S. mattress company to support the world-renowned hospital that impacts children globally.

8 May 2012

Oncothyreon first quarter net income increases to $9.7 million

Oncothyreon Inc. today reported financial results for the first quarter ending March 31, 2012.

8 May 2012

Researchers discover CD19 pathway that leads to lymphoma

Researchers studying the molecular signals that drive a specific type of lymphoma have discovered a key biological pathway leading to this type of cancer. Cancerous cells have been described as being "addicted" to certain oncogenes (cancer-causing genes), and the new research may lay the groundwork for breaking that addiction and effectively treating aggressive types of B cell lymphoma.

8 May 2012

Zinc oxide could increase risk of skin cancer

As vacationers prepare to spend time outdoors this summer, many of them will pack plenty of sunscreen in hopes it will protect their bodies from overexposure, and possibly from skin cancer. But researchers at Missouri University of Science and Technology are discovering that sunscreen may not be so safe after all.

8 May 2012

Otsuka announces results from aripiprazole Phase 3 trial on schizophrenia

Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S today announced results from a Phase 3 clinical trial evaluating the efficacy, safety and tolerability of once-monthly aripiprazole intramuscular (IM) depot formulation for the maintenance treatment of adults with schizophrenia.

8 May 2012

State roundup: Calif. fight over group homes for seniors; New agency proposed to police disabled care in NY; Conn. retiree health plan expansion could endanger protections

Neighbors were already concerned about the growing number of group homes for the elderly and recovering addicts in the area, many of them for profit. A Times analysis found 24 licensed facilities offering residential care for the elderly within a mile of the proposed project and three more waiting for state approval. It is one of several such clusters that have emerged in Los Angeles County -- including parts of the San Fernando Valley and South Bay -- where families can afford fees that run into thousands of dollars per month. Large swaths of the county's less affluent areas have no such facilities.

8 May 2012

Hologic features minimally invasive technologies at ACOG annual clinical meeting

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, is featuring minimally invasive technologies in surgical, diagnostic and skeletal health at The American College of Obstetricians and Gynecologists (ACOG) annual clinical meeting.

From Hologic, Inc. 7 May 2012

Monteris secures financing to commercialize NeuroBlate System

Monteris Medical Inc., a privately held medical device company dedicated to the development of innovative MRI guided, laser-based cancer treatments announced today it has secured $9 million in financing to support the continued commercialization of the company's NeuroBlate System (formerly AutoLITT) within the North American neurosurgery market.

7 May 2012

Latest science from area of network biology

This week experts from around the world will meet to discuss how network models can be applied to the study and targeting of complex diseases such as cancer, diabetes and neurological disorders.

7 May 2012

Cancer News and Research

Latest Cancer News and Research

Long-term exposure to roadways linked with increased risk of death in patients with heart attack

Research reveals possible strategy to reverse fibrosis in liver and other organs

iCAD first quarter total revenue decreases 14% to $6.3 million

Viewpoints: Diabetes, future health ills & the GOP; Debate on FDA OTC plan; Sen. Brown's daughter's health insurance

Breast cancer in men rarer but more deadly than in women

Cheaper anti-blindness drug could save NHS £85 million annually

Many unaware that persistent cough could be a warning for lung cancer

Can curry really be beneficial for cancer?

Pancreatic cancer could be better managed at specialized surgical centres

Halozyme first quarter net loss increases to $15.1 million

Salix first quarter total product revenue increases 62% to $171.1M

Comfort Solutions commits to raise $1M for St. Jude Children's Research Hospital

Oncothyreon first quarter net income increases to $9.7 million

Researchers discover CD19 pathway that leads to lymphoma

Zinc oxide could increase risk of skin cancer

Otsuka announces results from aripiprazole Phase 3 trial on schizophrenia

State roundup: Calif. fight over group homes for seniors; New agency proposed to police disabled care in NY; Conn. retiree health plan expansion could endanger protections

Hologic features minimally invasive technologies at ACOG annual clinical meeting

Monteris secures financing to commercialize NeuroBlate System

Latest science from area of network biology

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in